BALB/c mice (n = 6/group) were immunized i.n. with 10 μg/0.02 ml of Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e on days 0, 14, 28. Mice in the control group were administered with PBS. Two weeks post second boost, specific antibodies to purified viruses A/H2N2, A/H7N9, A/H3N2, A/H1N1pdm, and A/H5N1 were evaluated by ELISA. Statistical significance was determined using the Mann-Whitney U-test. The P values between immunized and control group are indicated. *—significant difference from control groups, p<0.05, **—significant difference from control groups, p<0.01.</p
<p>Groups of BALB/c mice (n = 5 per group) were inoculated (100 µl) sub-cutaneously at the base of t...
The titer of EV71 antibody in each of 5 groups of mice that received EV71 VLP (5μg), VLP (5μg) with ...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
Groups of 10 Balb/c mice were immunized with Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e fusion prot...
BALB/c mice (n = 6/group) were immunized i.n. with 10 μg/0.02 ml of Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, ...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>Sera from mice injected intramuscularly with PBS, AcHERV-GmCSF, killed vaccine alone, or killed v...
Aged (24–26 months) BALB/c mice were immunized twice with H1-VLP, split-virion vaccine or PBS. Three...
<p>Mice were immunised once by the i.n. (squares), s.c. (triangles) or i.m. (circles) routes with 10...
<p>Mice were immunized with PBS or three doses of the indicated amount of COPS:FliC. Serum was obtai...
<p>PBS was used as the negative control. (A) Reactivity of IgG antibody with HA1-Fc and HA1-Fdc prot...
<p>Mice were immunized vaginally with 20 nm NP-Ova or PBS (control), then s.c. boosted with 300 µg O...
<p>Mice were immunised once by the i.n. (squares), s.c. (triangles) or i.m. (circles) routes with 10...
<p>Mice were passively immunized before (A) or after (B) virus challenge with Aichi (H3) or WSN (H1)...
<p>Groups of BALB/c mice (n = 5 per group) were inoculated (100 µl) sub-cutaneously at the base of t...
The titer of EV71 antibody in each of 5 groups of mice that received EV71 VLP (5μg), VLP (5μg) with ...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
Groups of 10 Balb/c mice were immunized with Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e fusion prot...
BALB/c mice (n = 6/group) were immunized i.n. with 10 μg/0.02 ml of Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, ...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>Sera from mice injected intramuscularly with PBS, AcHERV-GmCSF, killed vaccine alone, or killed v...
Aged (24–26 months) BALB/c mice were immunized twice with H1-VLP, split-virion vaccine or PBS. Three...
<p>Mice were immunised once by the i.n. (squares), s.c. (triangles) or i.m. (circles) routes with 10...
<p>Mice were immunized with PBS or three doses of the indicated amount of COPS:FliC. Serum was obtai...
<p>PBS was used as the negative control. (A) Reactivity of IgG antibody with HA1-Fc and HA1-Fdc prot...
<p>Mice were immunized vaginally with 20 nm NP-Ova or PBS (control), then s.c. boosted with 300 µg O...
<p>Mice were immunised once by the i.n. (squares), s.c. (triangles) or i.m. (circles) routes with 10...
<p>Mice were passively immunized before (A) or after (B) virus challenge with Aichi (H3) or WSN (H1)...
<p>Groups of BALB/c mice (n = 5 per group) were inoculated (100 µl) sub-cutaneously at the base of t...
The titer of EV71 antibody in each of 5 groups of mice that received EV71 VLP (5μg), VLP (5μg) with ...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...